Spots Global Cancer Trial Database for A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Official Title: A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
Study ID: NCT05478083
Interventions
Study Description
Brief Summary: Multicenter trial on the effect of the GnRH analogue leuprorelin on the growth of total liver volume in pre-menopausal women with very severe polycystic liver disease who, despite available therapy, experience growth and are heading for liver transplantation.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Radboudumc, Nijmegen, Gelderland, Netherlands
Groningen universitair medical center, Groningen, , Netherlands
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
